Searched for
NOVARTIS SHARES
Who controls powerful AI? Anthropic has a plan for long after its leaders departAnthropic has filed for an IPO with a planned valuation of $1.5 trillion. The company has established a governance structure that ensures a...- Global Market: European shares fall as HSBC earnings drag banking stocksEuropean shares fell as HSBC's disappointing revenue weighed on banking stocks, while political unrest in France dampened investor sentimen...
- Anthropic's filing for blockbuster US IPO shows key executives and boardIn a significant step forward, Anthropic has filed for a US initial public offering, with hopes for a mid-November listing. Amid rising int...
- Indian banks open cheque books for ₹10,000 crore-plus in M&A funding after RBI rule changeIndian banks have recently engaged in significant M&A deals after the central bank eased financing rules. State Bank of India and other len...
- Europe’s last penicillin plant faces a bitter fight against China’s cheaper drugsThe Sandoz penicillin plant in Kundl, Austria, is under threat from cheaper Chinese antibiotic production. European healthcare programs ben...
- ‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
- Celldex shares slip 15% as safety concerns cloud skin drug trial win(Rewrites throughout to add company comments, adds shares in paragraph 2, analyst comment in paragraph 5)- Celldex Therapeutics said on Tue...
- Global funds, same tech bet? The diversification trap Indian investors may missMany Indian investors mistakenly believe they diversify their portfolios by adding foreign countries. However, numerous global indices ofte...
- Why US stocks are falling today: Dow Jones crashes 600 points on Trump threat to intensify US-Canada trade war amid oil price riseDow Jones dropped significantly as US President Donald Trump threatened Bombardier's market access. This escalation followed Canada's refus...
- Global Market: European shares slip as oil surge fuels inflation fears; Novartis plungesEuropean shares slipped as surging oil prices raised inflation concerns amid escalating Middle East tensions and threats to Gulf energy inf...
- European shares subdued as surging crude sharpens focus on ECB rate pathEuropean shares closed largely flat as higher oil prices and renewed US-Iran tensions raised inflation concerns, offsetting stronger euro z...
- 360 One Group CEO Bhagat buys 1.3 lakh shares of Novartis India for Rs 22 crKaran Bhagat acquired 1.3 lakh Novartis India shares for nearly Rs 22 crore. His firm Kyrush Investments sold an equal number of shares in ...
- Global Market: European stocks subdued as oil surge fuels inflation, ECB rate hike betsEuropean shares were subdued on Monday as rising oil prices sparked by US-Iran tensions renewed inflation fears. Investors are closely moni...
- Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...
- BSE shares fall over 3% from day’s high after report says NSE weighs trading shares on own platformBSE shares fell over 3% from the day’s high after a report said NSE may seek permission to trade its shares on its own platform following i...
- NSE said to plan allowing trading in its shares on its own platformNSE may allow its shares to trade on its own platform after listing on rival BSE, potentially boosting liquidity and paving the way for inc...
- Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore dealNovartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs 1,446 crore. A c...
- Novartis launches new share buyback of up to $15 blnThe Swiss pharma company confirmed it expected sales to grow by 4% or more through 2026. Its capital allocation strategy aims to combine in...
- Novartis concludes acquisition of 77% Alcon stake from NestleNovartis on Thursday said it has concluded a $28.3 billion deal with Alcon Inc that will give the Swiss drug-maker a controlling stake in t...
- Novartis looks to buy out Alcon for $38.5 bnDrug maker Novartis AG said Monday it plans to take over Alcon Inc. by paying $38.5 billion for the 77 percent stake.
Load More
